Inventiva Completes EIB Warrant Restructuring with New Issuance
Inventiva (NASDAQ:IVA) has completed the restructuring of its European Investment Bank warrants by issuing approximately 15.7 million new warrants and canceling all remaining legacy ones, aiming to simplify its capital structure and reduce future dilution risks.
Tickers: $IVA
Topics: biopharmaceutical capital_structure financial_flexibility